AlenCiken

$ANCN Announces Shareholder Approval of the Merger with Chemomab

NASDAQ:ANCN   None
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing

Anchiano shareholders approve all resolutions at shareholder meeting

The merged company is expected to receive approximate gross proceeds from the private financing of $45.5 million, which will be used to advance the Chemomab pipeline.

finance.yahoo.com/ne...erger-215400351.html

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.